5-溴-4-甲基-2-苯基-1,3-噻唑 | 28771-82-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 中文名称: 5-溴-4-甲基-2-苯基-1,3-噻唑
• 中文别名: 5溴-4-甲基-2-苯基-1,3-噻唑；5溴- 4 -甲基- 2 -苯基- 1,3 -噻唑
• 英文名称: 5-bromo-4-methyl-2-phenyl-1,3-thiazole
• 英文别名: 5-bromo-4-methyl-2-phenylthiazole；5-bromo-4-methyl-2-phenyl-thiazole；5-Brom-4-methyl-2-phenyl-thiazol
• CAS: 28771-82-6
• 化学式: C₁₀H₈BrNS
• 分子量: 254.15
• InChiKey: XNYKJKJMPCGEQI-UHFFFAOYSA-N

物化性质

• 熔点：
  60 °C
• 沸点：
  351.0±34.0 °C(Predicted)
• 密度：
  1.496±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4
• 重原子数：
  13
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  41.1
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 海关编码：
  2934100090

SDS

Name:	5-Bromo-4-methyl-2-phenyl-1 3-thiazole Material Safety Data Sheet
Synonym:	None Known
CAS:	28771-82-6

Section 1 - Chemical Product MSDS Name:5-Bromo-4-methyl-2-phenyl-1 3-thiazole Material Safety Data Sheet
Synonym:None Known

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
28771-82-6	5-Bromo-4-methyl-2-phenyl-1,3-thiazole	97+%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation. May cause chemical conjunctivitis.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
No information found.

---

Section 4 - FIRST AID MEASURES
Eyes: Immediately flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Immediately flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Wash clothing before reuse.
Ingestion:
Never give anything by mouth to an unconscious person. Get medical aid. Do NOT induce vomiting. If conscious and alert, rinse mouth and drink 2-4 cupfuls of milk or water. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If breathing is difficult, give oxygen. Get medical aid. Do NOT use mouth-to-mouth resuscitation. If breathing has ceased apply artificial respiration using oxygen and a suitable mechanical device such as a bag and a mask.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Vacuum or sweep up material and place into a suitable disposal container. Clean up spills immediately, observing precautions in the Protective Equipment section. Avoid generating dusty conditions.
Provide ventilation.

---

Section 7 - HANDLING and STORAGE
Handling:
Minimize dust generation and accumulation. Avoid breathing dust, vapor, mist, or gas. Avoid contact with eyes, skin, and clothing.
Keep container tightly closed. Avoid ingestion and inhalation. Use with adequate ventilation. Wash clothing before reuse.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 28771-82-6: Personal Protective Equipment Eyes: Wear appropriate protective eyeglasses or chemical safety goggles as described by OSHA's eye and face protection regulations in 29 CFR 1910.133 or European Standard EN166.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: Pale yellow
Odor: Not available.
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: Not available.
Freezing/Melting Point: 115 - 116 deg C
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water:
Specific Gravity/Density:
Molecular Formula: C10H8BrNS
Molecular Weight: 254.15

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Stable at room temperature in closed containers under normal storage and handling conditions.
Conditions to Avoid:
Incompatible materials, dust generation, excess heat.
Incompatibilities with Other Materials:
Strong oxidizing agents, strong acids.
Hazardous Decomposition Products:
Nitrogen oxides, carbon monoxide, oxides of sulfur, carbon dioxide, hydrogen bromide, bromine.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 28771-82-6 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
5-Bromo-4-methyl-2-phenyl-1,3-thiazole - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
IMO
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing Group:
RID/ADR
Shipping Name: Not regulated.
Hazard Class:
UN Number:
Packing group:

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 22 Do not breathe dust.
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 28771-82-6: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 28771-82-6 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 28771-82-6 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  5-溴-4-甲基-2-苯基-1,3-噻唑 在 palladium diacetate 苯乙烯 、 三乙胺 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 反应 48.0h， 以81%的产率得到4-甲基-2-苯基噻唑
  参考文献：
  名称：

  Sakamoto, Takao; Nagata, Hideo; Kondo, Yoshinori, Chemical and pharmaceutical bulletin, 1987, vol. 35, # 2, p. 823 - 828

  摘要：

  DOI：
• 作为产物：
  描述：

  4-甲基-2-苯基噻唑 在 溴 作用下， 以 二硫化碳 为溶剂， 以82%的产率得到5-溴-4-甲基-2-苯基-1,3-噻唑
  参考文献：
  名称：

  热不可逆的光致变色系统。1,2-双（噻唑基）全氟环戊烯的可逆光环化

  摘要：

  合成具有噻唑环，1，2-双（噻唑-4'-基）全氟环戊烯和1，2-双（噻唑-5'-基）全氟环戊烯的二芳烃。噻唑环与全氟环戊烯部分的结合位置强烈影响吸收光谱。1,2-双（5'-甲基-2'-苯基噻唑-4'-基）全氟环戊烯的开环和闭环形式的吸收最大值分别在300 nm和525 nm处观察到，而1,2-双（4'-甲基-2'-苯基噻唑-5'-基）全氟环戊烯移至363 nm（开环形式）和406 nm（闭环形式）。

  DOI：

  10.1016/s0040-4020(98)00330-5

文献信息

• Palladium-Catalyzed Cross-Coupling Reaction of Tricyclopropylbismuth with Aryl Halides and Triflates
  作者：Alexandre Gagnon、Martin Duplessis、Pamela Alsabeh、Francis Barabé

  DOI：10.1021/jo702377h

  日期：2008.5.1

  The palladium-catalyzed cross-coupling reaction of tricyclopropylbismuth with aryl and heterocyclic halides and triflates is reported. The reaction tolerates numerous functional groups and does not require anhydrous conditions. The method was successfully extended to the cross-coupling of triethylbismuth.

  报道了钯催化的三环丙基铋与芳基和杂环卤化物以及三氟甲磺酸酯的交叉偶联反应。该反应可耐受许多官能团，并且不需要无水条件。该方法已成功地扩展到三乙基铋的交叉偶联。
• Enantioselective, Palladium-Catalyzed α-Arylation of <i>N</i>-Boc Pyrrolidine: <i>In Situ</i> React IR Spectroscopic Monitoring, Scope, and Synthetic Applications
  作者：Graeme Barker、Julia L. McGrath、Artis Klapars、Darren Stead、George Zhou、Kevin R. Campos、Peter O’Brien

  DOI：10.1021/jo2011347

  日期：2011.8.5

  the process; use of (−)-sparteine and the (+)-sparteine surrogate to access products with opposite configuration; development of a catalytic asymmetric lithiation–Negishi coupling reaction; extension to a wide range of heteroaromatic bromides; total synthesis of (R)-crispine A, (S)-nicotine and (S)-SIB-1508Y via short synthetic routes; and examples of α-vinylation of N-Boc pyrrolidine using vinyl bromides

  已对N - Boc吡咯烷的对映选择性Pd催化的α-芳基化进行了全面研究。该方案包括在-78°C的条件下在TBME或Et 2 O中使用s -BuLi /（-）-天冬氨酸对N -Boc吡咯烷进行质子化，ZnCl 2的金属转移和使用Pd（OAc）2，t -Bu 3 P的Negishi偶联-HBF 4和芳基溴化物。本文报告了一些新功能，包括原位反应红外光谱监测过程；使用（-）-partaine和（+）-sparteine代理访问具有相反配置的产品；催化不对称锂化-Negishi偶联反应的发展；扩展到广泛的杂芳族溴化物；（R）-crispine A，（S）-尼古丁和（S）-SIB-1508Y通过短合成路线的全合成；以及使用乙烯基溴的N -Boc吡咯烷的α-乙烯基化的例子，其示例为天然存在的（+）-maackiamine的全合成（因此将其构型确定为（R））。以这种方式，描述了该方法的全部范围和局限性。
• INDOLE DERIVATIVES AS CRAC MODULATORS
  申请人：Alam Muzaffar

  公开号：US20110071150A1

  公开（公告）日：2011-03-24

  Compounds of the formula I: or pharmaceutically acceptable salts thereof, wherein R 1 , R 2 , R 3 and R 4 are as defined herein. Also disclosed are methods of making the compounds and using the compounds for treatment of diseases associated with calcium release-activated calcium channels (CRAC).

  公式I的化合物： 或其药用可接受的盐， 其中R1、R2、R3和R4按本文定义。还公开了制造这些化合物的方法以及使用这些化合物治疗与钙释放激活钙通道（CRAC）相关疾病的用途。
• 芳香族アミン化合物の製造方法と新規な芳香族アミン化合物および蛍光発光材料と紫外線吸収剤
  申请人：国立大学法人岐阜大学

  公开号：JP2018127451A

  公开（公告）日：2018-08-16

  【課題】新規なパラジウム触媒を用いたブッフバルト・ハートウィッグ反応による芳香族アミン化合物の製造方法、特に、従来技術においては反応が良好に進行しなかった基質であっても高い効率で目的化合物を得ることができる芳香族アミン化合物の製造方法、さらにはこれまでに合成例のない新規な芳香族アミン化合物を得ることも可能な芳香族アミン化合物の製造方法を提供する。また、新規な芳香族アミン化合物、５−アミノチアゾール化合物からなる新規な蛍光発光材料と紫外線吸収剤を提供する。【解決手段】本発明の芳香族アミン化合物の製造方法は、芳香族ハロゲン化合物と、アミン化合物とを、ホスフィン化合物を保護剤とするパラジウムナノ粒子および塩基の存在下に反応させ芳香族アミン化合物を得ることを特徴としている。【選択図】なし

  使用新型钯催化剂进行的布夫巴尔特·哈特威格反应制备芳香胺化合物的方法，特别是一种能够以高效率获得目标化合物的芳香胺化合物制备方法，即使是在传统技术中反应进展不良的底物也能够以高效率获得目标化合物的芳香胺化合物制备方法，甚至提供了一种可以获得迄今为止未合成过的新型芳香胺化合物的制备方法。此外，提供了一种新型芳香胺化合物、由5-氨基噻唑化合物组成的新型荧光发光材料和紫外线吸收剂。解决方案是，本发明的芳香胺化合物制备方法的特点在于将芳香卤化合物和胺化合物在磷化合物作为保护剂的钯纳米粒子和碱存在下反应，从而获得芳香胺化合物。【选择图】无
• MULTIHETEROARYL COMPOUNDS AS INHIBITORS OF H-PGDS AND THEIR USE FOR TREATING PROSTAGLANDIN D2 MEDIATED DISEASES
  申请人：Endres Gregory W.

  公开号：US20100075990A1

  公开（公告）日：2010-03-25

  Multiheteroaryl compounds, their preparation, pharmaceutical compositions comprising these compounds, and their pharmaceutical use in the prevention and treatment of prostaglandin D 2 mediated diseases and conditions that may be modulated by the inhibition of hematopoietic prostaglandin D synthase (H-PGDS).

  多杂环芳基化合物，它们的制备，包括这些化合物的药物组合物，以及它们在预防和治疗可能通过抑制造血前列腺素D合成酶（H-PGDS）调节的前列腺素D2介导的疾病和症状中的药用。